We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

FDA Grants Biovest International Fast Track Status for BiovaxID™

Biovest is now eligible to submit a biologics license application (BLA) on a rolling basis.
News

Clinical Development Program Utilizing Xenomics' DNA-Based Diagnostic Technology is Ranked Best in Europe

European Consortium led By Xenomics' collaborative venture with leading European research center prepares for euro 2 million funding of tuberculosis clinical program.
News

RCP Diagnostics Licenses Its Protein Marker to Biomarker Technologies

Biomarker will use the RCP marker only for the diagnosis of breast cancer.
News

OGeS and Medarex Sign Therapeutic Antibody Collaboration Agreement in Cancer

The collaboration combines OGeS' ability to discover targets for oncology with Medarex's expertise in the development of fully human antibody therapeutics.
News

Merck to Acquire Abmaxis

Acquisition further enhances Merck commitment and capabilities in biologics research and development.
News

Cytogen Announces FDA Clears IND for CYT-500

CYT-500 is a monoclonal antibody for the treatment of metastatic hormone-refractory prostate cancer.
News

Thermo Electron and Fisher Scientific to Combine in Industry-Transforming Transaction

Combination creates leading provider of laboratory products and services in the life, laboratory and health sciences industry.
News

J. Brian Munroe Elected President and Chairman of Personalized Medicine Coalition

Newly appointed vice president of WellPoint brings important payer constituency into coalition.
News

XOMA to Utilize AVEO’s Human Engineering™ Technology

XOMA will apply AVEO’s Human Engineering™ technology to humanize AV-299, AVEO's anti-HGF monoclonal antibody.
News

Millipore to Acquire Serologicals Corporation

The strategic combination of Millipore and Serologicals will strengthen Millipore's Bioscience Division.
Advertisement